It is exciting to speculate that the CSC in MDBMSCC undergo EMT and preferentially express OCT4, pSTAT3, SOX2, and NANOG and potentially lose the expression of EMA and CD44, as none of these cells outside of the tumor nests express EMA or CD44. This evidence concerns the gene NANOG and neoplasm.